SELECTIVE-INHIBITION OF CYTOMEGALOVIRUSES BY 9-(3'-ETHYLPHOSPHONO-1'-HYDROXYMETHYL-1'-PROPYLOXY-METHYL)GUANINE

被引:18
作者
BARNARD, DL [1 ]
HUFFMAN, JH [1 ]
SIDWELL, RW [1 ]
REIST, EJ [1 ]
机构
[1] SRI INT,MENLO PK,CA 94025
关键词
GANCICLOVIR; ANALOG; CYTOMEGALOVIRUSES; ANTIVIRAL; 3727A; 9-(3'-ETHYLPHOSPHONO-1'-HYDROXYMETHYL-1'-PROPYLOXYMETHYL)GUANINE;
D O I
10.1016/0166-3542(93)90086-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
9-(3'-ethylphosphono-1'-hydroxymethyl-1'-propyloxy-methyl)guanine (SR 3727A) was significantly inhibitory to strain AD169 of human cytomegalovirus (HCMV) utilizing plaque reduction and inhibition of intra- and extracellular virus yield in MRC-5 cells. The 50% effective concentrations (EC50) ranged from 6-17 muM for three laboratory strains of HCMV, whereas the 50% cytotoxic doses were > 4200 muM as determined by viable cell assay and inhibition of radiolabeled precursors into DNA, RNA and protein. EC50 values against ganciclovir-sensitive clinical isolates ranged from 8-47 muM. Against two ganciclovir-resistant strains of HCMV, EC50 Values of SR 3727A were 84 and 320 muM; against murine CMV (MCMV); 17 muM and against guinea pig CMV, 56 muM. SR 3727A was most effective when infected cells were treated 24 h or less after virus adsorption. BALB/c mice infected intraperitoneally (i.p.) with a lethal dose of MCMV were treated i.p. with 31.3, 62.5, 125, or 250 mg/kg/day of SR 3727 twice daily for 5 days beginning 4 h pre-virus inoculation. All doses were well tolerated; the 125 and 250 mg/kg/day doses significantly prevented death. In a second experiment, SR 3727 at 125 mg/kg/day markedly reduced titers of recoverable virus from spleens, kidneys, and salivary glands harvested at varying times after virus inoculation.
引用
收藏
页码:77 / 89
页数:13
相关论文
共 20 条
[1]  
BALFOUR HH, 1990, REV INFECT DIS, V12, pS849
[2]   EVALUATION OF THE ANTIVIRAL ACTIVITY OF ANTHRAQUINONES, ANTHRONES AND ANTHRAQUINONE DERIVATIVES AGAINST HUMAN CYTOMEGALOVIRUS [J].
BARNARD, DL ;
HUFFMAN, JH ;
MORRIS, JLB ;
WOOD, SG ;
HUGHES, BG ;
SIDWELL, RW .
ANTIVIRAL RESEARCH, 1992, 17 (01) :63-77
[3]  
CLEMENT JJ, 1991, TRANSPLANT P, V23, P159
[4]  
Drew W. L., 1993, Antiviral Research, V20, P55
[5]   PREVALENCE OF RESISTANCE IN PATIENTS RECEIVING GANCICLOVIR FOR SERIOUS CYTOMEGALOVIRUS-INFECTION [J].
DREW, WL ;
MINER, RC ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GULLETT, J ;
MEHALKO, SG ;
GORDON, SM ;
OWEN, WF ;
MATTHEWS, TR ;
BUHLES, WC ;
DEARMOND, B .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :716-719
[6]   INVITRO AND INVIVO ACTIVITIES OF PHOSPHATE DERIVATIVES OF 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)-GUANINE AGAINST CYTOMEGALOVIRUSES [J].
DUKE, AE ;
SMEE, DF ;
CHERNOW, M ;
BOEHME, R ;
MATTHEWS, TR .
ANTIVIRAL RESEARCH, 1986, 6 (05) :299-308
[7]   (+/-)-(1-ALPHA,2-BETA,3-ALPHA)-9-[2,3-BIS(HYDROXYMETHYL)-CYCLOBUTYL]GUANINE [(+/-)-BHCG OR SQ 33054] - A POTENT AND SELECTIVE INHIBITOR OF HERPESVIRUSES [J].
FIELD, AK ;
TUOMARI, AV ;
MCGEEVERRUBIN, B ;
TERRY, BJ ;
MAZINA, KE ;
HAFFEY, ML ;
HAGEN, ME ;
CLARK, JM ;
BRAITMAN, A ;
SLUSARCHYK, WA ;
YOUNG, MG ;
ZAHLER, R .
ANTIVIRAL RESEARCH, 1990, 13 (01) :41-52
[8]  
Freshney R.I., 2016, CULTURE ANIMAL CELLS
[9]   RAPID DETECTION OF CYTOMEGALOVIRUS IN MRC-5-CELLS INOCULATED WITH URINE SPECIMENS BY USING LOW-SPEED CENTRIFUGATION AND MONOCLONAL-ANTIBODY TO AN EARLY ANTIGEN [J].
GLEAVES, CA ;
SMITH, TF ;
SHUSTER, EA ;
PEARSON, GR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (06) :917-919
[10]  
GRUNDY JE, 1990, REV INFECT DIS, V12, pS711